Trial Profile
A Multicenter Double-Blind, Randomized Controlled Study of Etanercept and Methotrexate in Combination or as Monotherapy in Subjects With Psoriatic Arthritis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 22 Apr 2022
Price :
$35
*
At a glance
- Drugs Etanercept (Primary) ; Methotrexate (Primary)
- Indications Psoriatic arthritis
- Focus Registrational; Therapeutic Use
- Acronyms SEAM-PsA
- Sponsors Amgen
- 15 Apr 2022 Results of post-hoc analysis assessing the potential impact of sex and body mass index (BMI) on response in the SEAM-PsA trial, published in The Journal of Rheumatology.
- 30 Aug 2020 Results comparing the performance of composite measures published in the Rheumatology.
- 06 Jun 2020 Results assessing influence of sex and BMI at 24-week outcomes in a 48-wk PsA, presented at the 21st Annual Congress of the European League Against Rheumatism.